List of services: - Cancer Research Clinic focused on solid tumor immunotherapy & cellular therapy trials-Personalized Medicine: patient-driven biobanking of tumor infiltrating lymphocytes, leukapheresis, personalized tumor and immune profiling services.
Quick Bio/Introduction – Founded in 2005, Carolina BioOncology Institute (CBOI) is the only independent phase I cancer center with a Human Applications Lab for manufacturing cellular therapies. CBOI has opened > 140 early phase clinical trials and serves as a regional hub for Phase I access. Dr Powderly’s research on early phase immunotherapy trials has led to 137 publications, including the New England Journal of Medicine and Journal of Clinical Oncology, to name a few. He is also a reviewer for multiple cancer journals, a NIH grant reviewer, and is currently adjunct Clinical Assistant Professor of Medicine at both Duke and UNC. In 2014, he was awarded the David King Community Scientist Award by the Association of Community Cancer Centers (ACCC). Some of his articles and presentations have been recognized as "top 50 most-cited articles by JCO" and "top 10 most downloaded ASCO Video Presentations." Dr. Powderly’s research publications have been cited by more than 23,000 references in the scientific literature. He is currently developing an autologous T cellular immunotherapy platform with BioCytics, Inc., using autologous circulating tumor cells as the antigen source.